FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Authority Hl7

42,405 resources

Type: Text:

By Version

By Realm

 

Start Prev Rows 38800 - 39000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
hl7.fhir.eu.epsR4ValueSet/medical-devices-snomed-absent-unknown-eu-hdrMedical Devices - SNOMED CT + Absent/Unknown - IPSdraft12025-06eu
hl7.fhir.eu.hdrR4ValueSet/medical-devices-snomed-absent-unknown-eu-hdrMedical Devices - SNOMED CT + Absent/Unknown - IPSdraft12025-06eu
HIE2.packagesR4ValueSet/medication-snomed-uv-ipsMedications (SNOMED CT) - IPSactive2022-01uv
hl7.fhir.eu.epsR4ValueSet/medical-devices-eu-hdrMedical Devices (SNOMED CT)draft12025-06eu
hl7.fhir.eu.hdrR4ValueSet/medical-devices-eu-hdrMedical Devices (SNOMED CT)draft12025-06eu
hl7.fhir.eu.hdrR4ValueSet/procedures-snomed-absent-unknown-eu-hdrProcedures - SNOMED CT + Absent/Unknown - IPSdraft12025-06eu
hl7.fhir.eu.hdrR4ValueSet/procedure-snomed-eu-hdrProcedure codes: Snomed CTdraft12025-06eu
hl7.fhir.us.pacio-pfeR4ValueSet/pfe-category-vsPersonal Functioning and Engagement Category Value Settrial-use3pc2025-07us
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-type-vsAdverseEvent Typeinformativebrr2024-04uv
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-mitigating-action-vsAdverseEvent Mitigating Actioninformativebrr2024-04uv
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-seriousness-non-only-vsAdverseEvent Seriousness Non-serious Codes Onlyinformativebrr2024-04uv
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-contributing-factor-vsAdverseEvent Contributing Factorinformativebrr2024-04uv
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-supporting-infoAdverseEvent Supporting Informationinformativebrr2024-04uv
hl7.fhir.uv.ae-research-backport-igR4ValueSet/adverse-event-participant-function-vsAdverse Event Participant Functionsinformativebrr2024-04uv
hl7.terminologyR5ValueSet/adverse-event-clinical-research-outcomesAdverse Event Clinical Research Outcomesactive1brr2023-07uv
hl7.fhir.uv.phrR4ValueSet/pcd-sleep-observation-codePatient contributed data: sleep observation codeinformativepe2025-06uv
hl7.fhir.uv.phrR4ValueSet/pcd-sleep-observation-valuePatient contributed data: sleep stage valueinformativepe2025-06uv
hl7.fhir.us.carin-rtpbcR4ValueSet/rtpbc-prescribable-product-codeRTPBC Prescribable Product Code Value Settrial-use4phx2020-05us
signal.core.r4R4ValueSet/languagesCommon Languagesdraft5fm2016-08us
ee.hl7.fhir.base.r4R4ValueSet/eebase-actencountercodeEEBase ActEncounterCodedraft2022-09
hl7.terminologyR5ValueSet/ex-diagnosisrelatedgroupExample Diagnosis Related Group Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-diagnosistypeExample Diagnosis Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-diagnosis-on-admissionExample Diagnosis on Admission Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-paymenttypeExample Payment Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-procedure-typeExample Procedure Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-benefitcategoryBenefit Category Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/claim-subtypeExample Claim SubType Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/consent-actionConsent Action Codesactive1cbcc2024-04uv
hl7.terminologyR5ValueSet/contract-actionContract Action Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/contract-actorroleContract Actor Role Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/contract-signer-typeContract Signer Type Codesactivefm2024-04uv
hl7.terminologyR5ValueSet/contract-subtypeContract Subtype Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/contract-term-subtypeContract Term Subtype Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/contract-term-typeContract Term Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/contract-typeContract Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/coverage-copay-typeCoverage Copay Type Codesactive2fm2024-04uv
signal.core.r4R4ValueSet/coverage-copay-typeCoverage Copay Type Codestrial-use2fm2019-10us
hl7.terminologyR5ValueSet/claim-exceptionException Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/claim-informationcategoryClaim Information Category Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/missing-tooth-reasonMissing Tooth Reason Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/claim-modifiersModifier type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/payment-typePayment Type Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-program-codeExample Program Reason Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/provider-qualificationExample Provider Qualification Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/consent-policyConsent PolicyRule Codesactive2cbcc2024-04uv
hl7.terminologyR5ValueSet/related-claim-relationshipExample Related Claim Relationship Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/ex-revenue-centerExample Revenue Center Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/fundsreserveFunds Reservation Codesactive1fm2024-04uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1111.146Buprenorphineactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1111.166Codeine Schedule II and IIIactive2023-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1111.167Alfentanilactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1111.168Remifentanilactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1111.169Sufentanilactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1125.1Schedule IV Benzodiazepinesactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.11Oxycodoneactive2023-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.12Oxymorphoneactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.70Morphineactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.71Methadone Medicationsactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.72Meperidineactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.73Levorphanolactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.74Hydromorphoneactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.75Hydrocodoneactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.76Fentanylactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.12Butorphanolactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.15Opium Combinationsactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.16Pentazocineactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.17Tapentadolactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.18Tramadolactive2024-02us
hl7.terminologyR5ValueSet/adjudication-reasonAdjudication Reason Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/payment-adjustment-reasonPayment Adjustment Reason Codesactive1fm2024-04uv
hl7.fhir.us.mihrR4ValueSet/hypertensive-disorders-pregnancy-ICDValueSet – Hypertensive Disorders of Pregnancy ICDdraft2023-03us
hl7.fhir.us.mihrR4ValueSet/hypertensive-disorders-pregnancy-SNOMEDValueSet – Hypertensive Disorders of Pregnancy SNOMED CTdraft2023-03us
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-specialtySwissnoso Specialtyactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-organizational-unitSwissnoso Organizational Unitactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-germSwissnoso Germactive2022-06ch
hl7.fhir.us.eltssR4ValueSet/eltss-observation-codeObservation Code Value Setinformativehsswg2019-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.6Planned or Completed moodCodeactive2024-06us
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-bacterial-count-in-urineSwissnoso Bacterial Count in Urineactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-clinical-symptomSwissnoso Clinical Symptomactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-indicationSwissnoso Indicationactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-number-of-different-germsSwissnoso Number of Different Germsactive2022-06ch
ch.fhir.ig.swissnosoR4ValueSet/swissnoso-procedure-locationSwissnoso Procedure Locationactive2022-06ch
HIE2.packagesR4ValueSet/targetDiseases-uv-ipsVaccine Target Diseases - IPSactive2022-01uv
HIE2.packagesR4ValueSet/targetDiseases-gps-uv-ipsVaccine Target Diseases (GPS) - IPSactive2022-01uv
HIE2.packagesR4ValueSet/vaccines-gps-uv-ipsVaccines (GPS) - IPSactive2022-01uv
hl7.terminologyR5ValueSet/benefit-networkNetwork Type Codesactive1fm2025-05uv
hl7.terminologyR5ValueSet/process-priorityProcess Priority Codesactive1fm2024-04uv
hl7.terminologyR5ValueSet/consent-scopeConsent Scope Codesactive2cbcc2024-04uv
hl7.fhir.be.medicationR4ValueSet/BeMedicationLineRegistrationStatusVSMedication Line Registration Status Value Setdraft2025-07be
hl7.fhir.us.pacio-tocR4ValueSet/toc-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06us
hl7.fhir.us.pacio-tocR4ValueSet/toc-del-loinc-vsTransitions of Care DEL LOINC Terms Value Settrial-use2pc2025-06us
hl7.fhir.us.pacio-tocR4ValueSet/toc-del-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06us
hl7.terminologyR5ValueSet/medical-management-typeMedical Management Typeactive1fm2025-05uv
hl7.eu.fhir.idea4rcR4ValueSet/disease-extent-category-vsSarcoma Staging: localized diseasedraft2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/locoregional-category-vsStaging: loco-regional categorydraft2025-07eu
hl7.fhir.uv.cqmR4ValueSet/subject-typeSubject Type Value Settrial-use4cqi2024-08uv
hl7.fhir.uv.ipsR4ValueSet/problem-type-loincProblem Type (LOINC)trial-use2pc2025-08uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.28Problem Type (LOINC)active2023-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.39Result Statusactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.476Allergy To Vaccine Componentactive2023-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.2InstructionActStatusactive2017-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.7Obligation or Prohibition Instruction Typeactive2017-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.58Findings Related to Medication Management, Chronic Disease Presentactive2023-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.59Findings Related to Medication Management, Taking Medication for Chronic Diseaseactive2017-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.150Fall or Fall Risk from Wheelchair or Scooter ICD10CMactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.147Mobility Impairment or Fall From Chair ICD10CMactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1219.144Bed Confinement Impairmentactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.302Test Cervical Excision Proceduresactive2023-10us
HIE2.packagesR4ValueSet/core-problem-finding-situation-event-gps-uv-ipsCORE Problem List Finding/Situation/Event (GPS) - IPSactive2022-01uv
hl7.fhir.uv.ebmR6ValueSet/179431EvidenceReportSectionCode Value Setactive2025-08uv
hl7.fhir.us.coreR4ValueSet/us-core-screening-assessment-observation-maximum-categoryUS Core Screening Assessment Observation Maximum Categorytrial-use3cgp2024-11us
hl7.fhir.us.coreR4ValueSet/us-core-simple-observation-categoryUS Core Simple Observation Categorytrial-use3cgp2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.87Postpartum Statusactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.190123Diagnostic Mammography Studyactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1902Ultrasound of the Breastactive2019-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.190412Screening Mammography and DBT Studiesactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4066Diagnostic DBT Studyactive2022-05us
us.nlm.vsacR4ValueSet/2.16.840.1.13883.3.3157.4067MRI of the Breastactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.13883.3.3157.4068MRI of the Breastactive2022-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.25Detailed race including absence reasons.active2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.6Personal Health Goals LOINCactive2024-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.13Healthcare Agent Powers or Limitations Indicatoractive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.208Sexual Orientationactive2024-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.264CDS Pregnancyactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.265CDS Pregnancy Intensionalactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.11Cirrhosis ICD9CMactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.13Cirrhosis SNOMEDCTactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.14Cirrhosisactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.179Abortion Medicationsactive2024-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.184Letrozole (Aromatase inhibitor)active2024-04us
hl7.fhir.uv.genomics-reportingR4ValueSet/molecular-biomarker-category-vsMolecular Biomarker Categoriesinformativecg2025-06uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.12Negativeactive2023-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1095.11Nutrition Focused Physical Findings SNOMED CTactive2025-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.207PharmacyEnvironmentsOfCareactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.205PharmacyTypeOfProfessionactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.181PharmacyEncounterReasonactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.197PharmacyAllergiesactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.198PharmacyInterventionsactive2024-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.200PharmacyReasonsForInterventionsactive2024-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.201PharmacyInterventionStatusactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.202PharmacyCareCoordinationactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.203PharmacyReferralsToactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.204PharmacyGoalStatusOutcomeactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.208PharmacyEncounterTypeactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.209PharmacytEncounterClassactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.211PharmacyAllergyIntoleranceTypeactive2018-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.212PharmacyAllergyIntoleranceManifestationactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.213PharmacyReasonForMedicationChangeactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.214PharmacyEducationactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.215PharmacyEducationStatusactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.216PharmacyReferralsFromactive2022-03us
hl7.eu.fhir.pcspR4ValueSet/mcode-cancer-stage-group-vsStage Group Value Setdraft2025-08eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-distant-metastases-category-clinical-vsTNM Distant Metastases Category Value Set (Clinical)draft2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-distant-metastases-category-pathological-vsTNM Distant Metastases Category Value Set (Pathological)draft2025-07eu
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-distant-metastases-category-vsTNM Distant Metastases Category Value Setdraft2025-08eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-regional-nodes-category-clinical-vsTNM Regional Nodes Category Value Set (Clinical)draft2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-regional-nodes-category-pathological-vsTNM Regional Nodes Category Value Set (Pathological)draft2025-07eu
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-regional-nodes-category-vsTNM Regional Nodes Category Value Setdraft2025-08eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-clinical-tnm-primary-tumor-category-vsClinical TNM Primary Tumor Category Value Setdraft2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-pathological-tnm-primary-tumor-category-vsPathological TNM Primary Tumor Category Value Setdraft2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-primary-tumor-category-vsTNM Primary Tumor Category Value Setdraft2025-07eu
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-primary-tumor-category-vsTNM Primary Tumor Category Value Setdraft2025-08eu
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.7Health Goals Groupingactive2022-03us
hl7.terminologyR5ValueSet/reason-medication-given-codesReason Medication Given Codesactive1phx2024-04uv
hl7.fhir.uv.extensionsR5ValueSet/procedure-progress-status-codesProcedure Progress Status Codes Value Settrial-use3pc2025-08uv
hl7.fhir.uv.extensionsR5ValueSet/flag-priorityFlag Priority Codes Value Settrial-use3pc2025-08uv
hl7.fhir.uv.order-catalogR5ValueSet/laboratory-service-typeTypes of diagnostic services performed by a laboratorytrial-use2oo2019-12uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1221.177Mifepristoneactive2024-04us
hl7.fhir.uv.cowR4ValueSet/business-statusClinical Orders Workflow Business Status Codestrial-use1oo2025-05uv
hl7.fhir.us.coreR4ValueSet/us-core-screening-assessment-observation-categoryUS Core Screening Assessment Observation Categorytrial-use3cgp2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.107Mechanical Ventilationactive2022-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.109aPTT Testsactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.106Mechanical Ventilationactive2024-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.96Dependence on dialysisactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.117Syphilis Testsactive2023-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.9Nutrition Recommendationsactive2018-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.15913EntityNameUseactive2024-06us
ch.fhir.ig.ch-lab-reportR4ValueSet/ch-lab-bloodgroup-immuno-hematology-vsCH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures)draft2024-05ch
ch.fhir.ig.ch-lab-reportR4ValueSet/ch-lab-bloodgroup-antibody-vsCH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances)active2024-05ch
ch.fhir.ig.ch-lab-reportR4ValueSet/ch-lab-bloodgroup-antibody-screen-vsCH LAB-Report BloodGroup Antibody Screen Test (LOINC codes)draft2024-05ch
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1116.365Hospice Care Referral or Admissionactive2025-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.2Abdomen CT with contrastactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.21Abdomen CT Without then With Contrastactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1Abdomen CT without contrastactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1017Adrenal Massactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1020Hematuriaactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1021Infections of Kidneyactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1022Jaundiceactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1023Liver Lesion (Mass or Neoplasm)active2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1024Malignant Neoplasm of Bladderactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1025Malignant Neoplasm of Pancreasactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1026Non Traumatic Aortic Diseaseactive2023-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1028Unspecified Disorder of Kidney and Ureteractive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1805MRI Lumbar Spine Proceduresactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1802Physical Therapyactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1812Biomechanical Lesions (not Elsewhere Classified)active2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1809Other Deforming Dorsopathiesactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1813Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvisactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1811Other Dorsopathiesactive2021-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1810Spondylopathiesactive2020-07us